PRINCY GEORGE: Open Payments
NPI 1922842608 · MONROE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $40 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| SANOFI-AVENTIS U.S. LLC | 2 | $52 |
| Amgen Inc. | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Viatris Specialty LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: TZIELD, Wegovy, OPSUMIT, Ozempic, MOUNJARO, Kerendia, XIFAXAN, CAPVAXIVE.
Industry payments across GA — which companies pay providers there.
